MAQAF has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MAQAF has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Atlas Arteria's Enterprise Value is $5,176.35 Mil. Atlas Arteria's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $224.49 Mil. Therefore, Atlas Arteria's EV-to-EBIT for today is 23.06.
The historical rank and industry rank for Atlas Arteria's EV-to-EBIT or its related term are showing as below:
During the past 13 years, the highest EV-to-EBIT of Atlas Arteria was 328.71. The lowest was -104.01. And the median was 25.55.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Atlas Arteria's Enterprise Value for the quarter that ended in Jun. 2024 was $5,813.47 Mil. Atlas Arteria's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $224.49 Mil. Atlas Arteria's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 3.86%.
The historical data trend for Atlas Arteria's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Atlas Arteria Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
EV-to-EBIT | Get a 7-Day Free Trial | 81.77 | 318.71 | 31.07 | 32.23 | 35.53 |
Atlas Arteria Semi-Annual Data | ||||||||||||||||||||
Dec14 | Jun15 | Dec15 | Jun16 | Dec16 | Jun17 | Dec17 | Jun18 | Dec18 | Jun19 | Dec19 | Jun20 | Dec20 | Jun21 | Dec21 | Jun22 | Dec22 | Jun23 | Dec23 | Jun24 | |
EV-to-EBIT | Get a 7-Day Free Trial | - | 32.23 | - | 35.53 | - |
For the Infrastructure Operations subindustry, Atlas Arteria's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Construction industry and Industrials sector, Atlas Arteria's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Atlas Arteria's EV-to-EBIT falls into.
Atlas Arteria's EV-to-EBIT for today is calculated as:
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 5176.352 | / | 224.49 | |
= | 23.06 |
Atlas Arteria's current Enterprise Value is $5,176.35 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Atlas Arteria's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $224.49 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Atlas Arteria (OTCPK:MAQAF) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.
Atlas Arteria's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:
Earnings Yield (Joel Greenblatt) % (Q: Jun. 2024 ) | = | EBIT | / | Enterprise Value (Q: Jun. 2024 ) |
= | 224.49 | / | 5813.4685 | |
= | 3.86 % |
Atlas Arteria's Enterprise Value for the quarter that ended in Jun. 2024 was $5,813.47 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Atlas Arteria's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $224.49 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Atlas Arteria's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
From GuruFocus
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 09-13-2024
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 09-13-2024
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 02-14-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.